To determine how mutations other than those in the ABL1 gene affect chronic myeloid leukemia (CML) prognosis, researchers identified 115 patients with CML where targeted next-generation sequencing of genes recurrently mutated in myeloid leukemias was performed.
[Blood Cancer Journal]

Cancer Stem Cell News
Cell Therapy News
Dermal Cell News
Endothelial Cell News
ESC & iPSC News
Extracellular Matrix News
Hematopoiesis News
Hepatic Cell News
Human Immunology News
Immune Regulation News
Intestinal Cell News
Mammary Cell News
Mesenchymal Cell News
Muscle Cell News
Neural Cell News
Organoid News
Pancreatic Cell News
Prostate Cell News
Pulmonary Cell News